Literature DB >> 21679590

Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.

Michihiro Hayashi1, Tetsunosuke Shimizu, Fumitoshi Hirokawa, Yoshihiro Inoue, Koji Komeda, Mitsuhiro Asakuma, Yoshiharu Miyamoto, Atsushi Takeshita, Yuro Shibayama, Nobuhiko Tanigawa.   

Abstract

Hepatocellular carcinoma (HCC) shows a high rate of recurrence after hepatectomy; predictive factors for early recurrence would help determine optimal therapeutic and management strategies. Among 163 patients with HCC undergoing hepatectomy with curative intent, 46 patients developed recurrence within 1 year. Clinicopathological data were retrospectively analyzed to identify predictive parameters for early recurrence. Survival rates in cases of recurrence within 1 year were worse than those of no recurrence within 1 year or recurrence after 1 year. Protein induced by vitamin K absence/antagonist II (PIVKA-II) greater than 150, positive fucosylated alpha-fetoprotein (L3-AFP), and deviancy from Milan criteria (MC) on preoperative imaging were associated with high risk of early recurrence and total number of these three risk factors predicted the survival. With multivariate analysis, (1) preoperatively, positive factors of two or more among three items of PIVKA-II, L3-AFP, and deviancy from MC; (2) and postoperatively, pathological cancer spread (microscopic vascular invasion and/or intrahepatic metastasis) both represented risks for early recurrence. A combination of three preoperative factors, PIVKA-II, L3-AFP, and MC status, in conjunction with the postoperative factor of cancer spread status represents a significant indicator for recurrence within 1 year. Improving the prognosis of patients with HCC would depend on how to adequately treat those at high risk of early recurrence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679590

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma.

Authors:  Sung-Mi Jung; Jong Man Kim; Gyu-Seong Choi; Choon Hyuck David Kwon; Nam-Joon Yi; Kwang-Woong Lee; Kyung Suk Suh; Jae-Won Joh
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

2.  Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Yusuke Yamamoto; Hisashi Ikoma; Ryo Morimura; Hirotaka Konishi; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Takeshi Kubota; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chouhei Sakakura; Toshiya Ochiai; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

3.  Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinoma.

Authors:  Ming-Chin Yu; Tsung-Han Wu; Chao-Wei Lee; Yun-Shien Lee; Jang-Hau Lian; Chia-Lung Tsai; Sen-Yung Hsieh; Chi-Neu Tsai
Journal:  Biomed J       Date:  2020-07-15       Impact factor: 7.892

4.  The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment.

Authors:  Bong Kyung Bae; Hee Chul Park; Gyu Sang Yoo; Moon Seok Choi; Joo Hyun Oh; Jeong Il Yu
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

5.  Fluorescence imaging of hepatocellular carcinoma with a specific probe of COX-2.

Authors:  Haibo Wang; Chengyong Dong; Keqiu Jiang; Shuangzhe Zhang; Fei Long; Rixin Zhang; Deguang Sun; Rui Liang; Zhenming Gao; Shujuan Shao; Liming Wang
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 3.361

6.  Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria.

Authors:  Shuqi Zhang; Liangliang Xu; Fuzhen Dai; Peng Wang; Jianchen Luo; Ming Zhang; Mingqing Xu
Journal:  Ann Transl Med       Date:  2022-08

7.  Smoking as an Independent Risk Factor for Hepatocellular Carcinoma Due to the α7-Nachr Modulating the JAK2/STAT3 Signaling Axis.

Authors:  Ching-Li Li; Yen-Kuang Lin; Hsin-An Chen; Chien-Yu Huang; Ming-Te Huang; Yu-Jia Chang
Journal:  J Clin Med       Date:  2019-09-05       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.